Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! 2nd Global Bioequivalence Harmonisation Initiative – a great success Quality Management Systems in Early Phase Trials Trial in drug-induced xerostomia published Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Local tolerability Oncology Rhine Main area Drug Drug Interaction Eye disease SOP based Clinical trials Source Data Verification Product development Immunogenicity Cough In vitro in vivo correlation Clinical study Clinical Monitoring Central surveillance system Ovulation inhibition Biopharmaceutical Statistical programming Patch adhesion Pragmatism Inhalatives Data Management Plan Phase IIb trials Patient recruitment Asthma Pharmacokintetics Database Phase IIa trials ICF Investigators brochure Competence Children Edema Female adolescents EMA Thuringia US FDA Pharmacology Quality Assurance Feasibility Statistical Analysis Plan First in human IVIVC CDSIC US CFR 21 Part 11 Bioavailability DUS PAES Xerostomia Clinical pharmacology unit FIM GLP Dose linearity Scientific expertise Dry powder inhaler Sample size estimation Biometrics Elpro Pharmacokinetics Project Management Referral system TTS MCID Safety Glaucoma Training Life cycle management Patch Postmenopausal women Protocol Scientific advice Clinical development program Post authorisation Audit Ophthalmologist CRF Cardiovascular surveillance Protocol development Copyright Adrenocortical Centralised procedure Paediatricians Oncological patients Steady state Legal Information Consultancy HRT Allergy Ophthalmology Dermal irritation Healthy subjects Legal representative Data Validation Plan Absorption windows IB Phase I Unit Inspection Charcoal Standardisation Informed Consent Procedure Absorption Hypothalamic Authorities Biosimilars Phase II Endpoint OTC Transdermal therapeutic system Phase III NIS Sequential designs Subcontractor qualification Axis CDISC Non interventional Network Pulse oximetry plethysmography Sore throat CDASH ADAM ANVISA MDI WinNonlin CRO AGAH Highly variable drugs PASS Anaesthesiologist Common cold Creativity Metered dose inhaler Monitoring Pharmacodynamic studies Statistical services Bioequivalence IMPD Quality Intensive assessment station Macular Phase IV Slit lamp microscopy Uveitis DPI CDM Sensitisation trials Spacious archive Oncologic network SDV Design development Data management Pituitary MMM Patients SocraTec C&S Dry eye Quality Management System Early phase Standard operating procedure COPD FDA Drug Food Interaction DFI Ophthalmological trials Degeneration Contraception Expert Recruitment rates DDI GCP training HPA axis Lung Biopharmaceutics Good Clinical Practice Pilot study Experience Gynaecological trials CRA HTA GCP Ocular tolerability Hormone replacement therapy IEC Efficacy SAS Auditing Phase I  
 
Menu

All fine on front page